Exact Sciences Corporation entered into an agreement to acquire Omicera Diagnostics Gmbh for approximately $14.6 million on March 11, 2022. 265,186 shares of Exact Sciences Corporation will issues as consideration to shareholders of Omicera Diagnostics Gmbh.

Exact Sciences Corporation completed the acquisition of Omicera Diagnostics Gmbh for $19.41 million on May 2, 2022. As part of the acquisition, Exact Sciences issued 265,186 common shares, contingent consideration of $4.6 million, Working capital adjustment to be settled in cash of $0.016 million and maximum of $6 million of additional cash consideration to OmicEra upon the achievement of certain earnout conditions.